Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 792-797

  Athale, Uma ^a,b   Siciliano, Sabrina ^b   Thabane, Lehana ^a,c,d   Pai, Nikhil ^a   Cox, Stephanie ^b   Lathia, Anita ^a   Khan, Anees ^a,b   Armstrong, Ankelly ^a   Chan, Anthony K C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Cancer; Central venous line dysfunction; Children; Intra thoracic disease; Thromboembolism

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; CENTRAL VEIN; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SARCOMA; SEX DIFFERENCE; THORAX TUMOR; THROMBOEMBOLISM;

BRAIN NEOPLASMS; CATHETERIZATION, CENTRAL VENOUS; CHILD; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LYMPHOMA; MALE; NEOPLASMS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; THROMBOEMBOLISM;

EID: 56849084689     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21734     Document Type: Article

References (41)

1. Lyman GH, Khorana AA, Falanga A, et al. American society of clinical oncology guideline: Recommendations for venous thromboembolism and treatment in patients with cancer. J Clin Oncol 2007;25:1-16.
2. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007;5:632-634.
3. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006;24:484-490.
4. Lee AYY, Levine MN. Venous thromboembolism and cancer: Risks and outcome. Circulation 2003;107:I-17-I-21.
5. Stein PD, Beemath A, Meyers FA, et al. Incidence of thromboembolism in patients hospitalized with cancer. Am J Med 2006;119:60-68.
6. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000;47:763-766.
7. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian registry of venous thromboembolic complications. J Pediatr 1998;133:770-776.
8. van Ommen CH, Heijboer H, Baller HR, et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001;139:676-681.
9. Athale UH, Chan AKC. Thrombosis in children with acute lymphoblastic leukemia Part I: Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 2003;111:125-131.
10. Athale UH, Chan AKC. Thromboembolic complications in pediatric hematologic malignancies. Semin Thromb Hemost 2007;33:416-426.
11. Athale UH, Chan AKC. Thrombosis in children with acute lymphoblastic leukemia Part II: Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: Effects of the disease and therapy. Thromb Res 2003;111:199-212.
12. Nowak-Gottl U, Munchow N, Klippel U, et al. The course of fibrinolytic proteins in children with malignant bone tumors. Eur J Pediatr 1999;158:S151-S153.
13. Mitchell LG, Andrew M, Hanna K, et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Results of the prophylactic anti-thrombin replacement in kids with acute lymphoblastic leukemia treated with asparaginase (PARKAA) study. Cancer 2003;97:508-516.
14. Ruud E, Holmstrome H, De Lange C, et al. Lowdose warfarin or the prevention of central line-associated thrombosis in children with malignancy - a randomized controlled study. Acta Paediatr 2006;95:1053-1059.
15. Athale UH, Siciliano SA, Cowther M, et al. Thromboembolism in children with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute protocols: Effect of age and risk stratification of disease. Br J Haematol 2005;129:803-810.
16. Nowak-Gottl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999;93:1595-1599.
17. Mauz- Korholz C, Junker R, Gobel U, et al. Prothrombotic risk factors in children with acute lymphoblatic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols). Thromb Haemost 2000;83:840-843.
18. Nowak-Gottl U, Heinecke A, von Kries R, et al. Thrombotic events revisited in children with acute lymphoblastic leukemia. Impact of concomitant Escherichia coli asparaginase/prednisone administration. Thromb Res 2001;103:165-172.
19. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005;23:3024-3029.
20. Caruso V, Iacoviello L, Di Castenuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: A meta-analysis of 17 prospective studies comprising 1742 patients. Blood 2006;108:2216-2222.
21. Wermes C, Prondzinski MvD, Lichtinghagen R, et al. Clinical relevance of genetic risk factors for thrombosis in pediatric oncology patients with central venous catheters. Eur J Pediatr 1999; 158:S143-S146.
22. Knoffler R, Siegert E, Lauterbach I, et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy: Impact of central venous lines. Eur J Pediatr 1999;185:S147-S150.
23. Athale U, Cox S, Siciliano S, et al. Thromboembolism in children with sarcoma. Pediatr Blood Cancer 2007;49:171-176.
24. Paz-Priel I, Long L, Helman LJ, et al. Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol 2007;25:1519-1524.
25. Silverman LB, DeClerck L, Gelber RD, et al. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 2000;14:2247-2256.
26. Children's Oncology group. http://childrensoncologygroup.org/ (Date of last access January 15, 2008).
27. Babyak MA. What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004;66:411-421.
28. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-1379.
29. Tabori U, Beni-Adani L, Dvir R, et al. Risk of venous thromboembolism in pediatric patients with brain tumors. Pediatr Blood Cancer 2004;43:633-636.
30. Deitcher SR, Gajjar A, Kun L, et al. Clinically evident venous thromboembolism in children with brain tumors. J Pediatr 2004;145:848-850.
31. Athale UH, Nagel K, Khan AA, et al. Thromboembolism in children with lymphoma. Thromb Res 2008;122:459-465.
32. Journycake JM, Buchanan GR. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol 2006;24:4575-4580.
33. Lee AY, Levine MN, Butler G, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006;24:1404-1408.
34. Senrad TJ, O'Donnell R, Wun T, et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 2007;106:601-608.
35. Berber DE, Grossman SA, Streiff MD. Management of venous thromboembolism in patients with primary and metastatic brain tumor. J Clin Oncol 2006;24:1310-1318.
36. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
37. Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants, and children. Thromb Haemost 2001;86:464-474.
38. Mongale P, Michelson AD, Bovil E, et al. Antithrombotic therapy in children. Chest 2001;119:344-370.
39. Monagle P, Chan AKC, Albisetti M, et al. Fibrinolytic system in adolescents; Response to venous occlusion stress tests. Pediatr Res 2003;53:333-337.
40. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the canadian registry of venous thromboembolic complications. J Pediatr 1998;133:770-776.
41. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/hematological diseases: An observational study of 418 devices. Ann Oncol 2005;16:648-654.